142
Views
10
CrossRef citations to date
0
Altmetric
Review

Assessing the risk of recurrent venous thromboembolism – a practical approach

, , &
Pages 451-459 | Published online: 17 Aug 2015

References

  • WhiteRHThe epidemiology of venous thromboembolismCirculation2003107I4I812814979
  • HeitJAMohrDNSilversteinMDPredictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort studyArch Intern Med200016076176810737275
  • ChristiansenSCCannegieterSCKosterTThrombophilia, clinical factors, and recurrent venous thrombotic eventsJAMA20052932352236115900005
  • KearonCKahnSRAgnelliGAntithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Chest2008133454S545S18574272
  • GuyattGHAklEACrowtherMExecutive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest20121417S47S22315257
  • van AkenBEden HeijerMBosGMRecurrent venous thrombosis and markers of inflammationThromb Haemost20008353653910780312
  • BoutitieFPinedeLSchulmanSInfluence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants’ data from seven trialsBMJ2011342d303621610040
  • WhiteRHBeythRJZhouHMajor bleeding after hospitalization for deep-venous thrombosisAm J Med199910741442410569295
  • HeitJALahrBDPettersonTMHeparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort studyBlood20111184992499921890644
  • KearonCAklEAComerotaAJAntithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest2012141e419Se494S22315268
  • LipGYFrisonLHalperinJLComparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) scoreJ Am Coll Cardiol20115717318021111555
  • FangMCGoASChangYA new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) StudyJ Am Coll Cardiol20115839540121757117
  • GageBFYanYMilliganPEClinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)Am Heart J200615171371916504638
  • ApostolakisSLaneDAGuoYPerformance of the HEMORR(2) HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) studyJ Am Coll Cardiol20126086186722858389
  • NietoJASolanoRRuiz-RiboMDFatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: findings from the RIETE registryJ Thromb Haemost201081216122220345727
  • EichingerSHeinzeGJandeckLMRisk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction modelCirculation20101211630163620351233
  • EichingerSHeinzeGKyrlePAD-dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction modelJ Am Heart Assoc20143e00046724385451
  • MarcucciMIorioADouketisJDRisk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient dataJ Thromb Haemost201513577578125660555
  • TosettoAIorioAMarcucciMPredicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)J Thromb Haemost2012101019102522489957
  • RodgerMAKahnSRWellsPSIdentifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapyCMAJ200817941742618725614
  • PrandoniPNoventaFGhirarduzziAThe risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patientsHaematologica20079219920517296569
  • GalanaudJPSevestreMAGentyCIncidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosisJ Thromb Haemost20141243644324450376
  • BaglinTDouketisJTosettoADoes the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysisJ Thromb Haemost201082436244220723032
  • DouketisJDFosterGACrowtherMAClinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapyArch Intern Med20001603431343611112236
  • WhiteRHMurinSWunTRecurrent venous thromboembolism after surgery-provoked versus unprovoked thromboembolismJ Thromb Haemost2010898799720149075
  • IorioAKearonCFilippucciERisk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic reviewArch Intern Med20101701710171620975016
  • HronGEichingerSWeltermannAFamily history for venous thromboembolism and the risk for recurrenceAm J Med2006119505316431184
  • EichingerSHronGBialonczykCOverweight, obesity, and the risk of recurrent venous thromboembolismArch Intern Med20081681678168318695082
  • McRaeSTranHSchulmanSEffect of patient’s sex on risk of recurrent venous thromboembolism: a meta-analysisLancet200636837137816876665
  • ChristiansenSCLijferingWMHelmerhorstFMSex difference in risk of recurrent venous thrombosis and the risk profile for a second eventJ Thromb Haemost201082159216820738758
  • DouketisJTosettoAMarcucciMRisk of recurrence after venous thromboembolism in men and women: patient level meta-analysisBMJ2011342d81321349898
  • PalaretiGCosmiBLegnaniCD-dimer testing to determine the duration of anticoagulation therapyN Engl J Med20063551780178917065639
  • DouketisJTosettoAMarcucciMPatient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolismAnn Intern Med201015352353120956709
  • KearonCSpencerFAO’KeeffeDD-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort studyAnn Intern Med2015162273425560712
  • SiragusaSMalatoAAnastasioRResidual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) studyBlood200811251151518497320
  • CarrierMRodgerMAWellsPSResidual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysisJ Thromb Haemost201191119112521382171
  • MarchioriAMosenaLPrinsMHThe risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studiesHaematologica2007921107111417650440
  • CohnDVansenneFde BorgieCThrombophilia testing for prevention of recurrent venous thromboembolismCochrane Database Syst Rev20091CD00706919160316
  • CohnDMVansenneFde BorgieCAThrombophilia testing for prevention of recurrent venous thromboembolismCochrane Database Syst Rev201212CD00706923235639
  • NovacekGWeltermannASobalaAInflammatory bowel disease is a risk factor for recurrent venous thromboembolismGastroenterology2010139779787787.e120546736
  • PengoVRuffattiALegnaniCClinical course of high-risk patients diagnosed with antiphospholipid syndromeJ Thromb Haemost2010823724219874470
  • WhiteRHZhouHRomanoPSIncidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in CaliforniaAnn Intern Med19981287377409556467
  • PrandoniPLensingAWPiccioliARecurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosisBlood20021003484348812393647
  • Lindhoff-LastERisk assessment of recurrence of venous thromboembolismHamostaseologie201131712 quiz 1321152680
  • AklEABarbaMRohillaSAnticoagulation for the long term treatment of venous thromboembolism in patients with cancerCochrane Database Syst Rev20087CD006650
  • LeeAYLevineMNBakerRILow-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancerN Engl J Med200334914615312853587
  • LouzadaMLCarrierMLazo-LangnerADevelopment of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolismCirculation201212644845422679142
  • den ExterPLKooimanJHuismanMVValidation of the Ottawa prognostic score for the prediction of recurrent venous thromboembolism in patients with cancer-associated thrombosisJ Thromb Haemost201311998100023496788
  • BrightonTAEikelboomJWMannKLow-dose aspirin for preventing recurrent venous thromboembolismN Engl J Med20123671979198723121403
  • BecattiniCAgnelliGSchenoneAAspirin for preventing the recurrence of venous thromboembolismN Engl J Med20123661959196722621626
  • SimesJBecattiniCAgnelliGAspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaborationCirculation2014130131062107125156992